bpi labs tirzepatide reddit BPILabs General Presentation Tirzepatide Sell Sheet R0924

In patients with type 2 diabetes and high cardiovascularrisk, clinical trials have shown that GLP-1 receptor agonistsreduce the incidence of major adverse cardiovascular events.The effect of tirzepatide a dual incretin agonist of theGLP-1 and GIP receptors on cardiovascular outcomes isuncertain. In theSURPASS-CVOTtrial, patients40 years of age or older with type 2 diabetes, a BMIof at least 25, and atherosclerotic cardiovascular disease wererandomly assigned to receive a weekly subcutaneous injectionof tirzepatide (up to 15 mg) or dulaglutide (1.5 mg), a GLP-1receptor agonist that has been shown to reduce the incidenceof cardiovascular events

Acting as a metabolic amplifier, it helps enhance insulin sensitivity, reduce visceral fat, and increase resting energy expenditure

Healthy Metabolism

2) High leucine content Whey is naturally rich in leucine, the amino acid that triggers muscle protein synthesis

They can ...